Operating cash flow swung from -$167.4M in 2026Q1 to $293.0M in 2026Q2, but claims payouts surged 13-fold to $957.4M, and shareholder returns of $277.1M nearly matched OCF, indicating potential liquidity strain.
Ryan Specialty Holdings, Inc. (RYAN) cash flow statement — 7-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Cash from Operations | 558.52M | 643.67M | 514.87M | 477.2M | 335.51M | 273.49M | 135.39M | 149.51M |
| Operating CF Growth % | 35.13% | 25.02% | 7.89% | 42.23% | 22.68% | 102% | -9.44% | - |
| Operating CF / Revenue % | 17.36% | 21.1% | 20.47% | 22.97% | 19.45% | 19.09% | 13.3% | 19.54% |
| Net Income | 188.04M | 214.16M | 229.91M | 194.48M | 163.26M | 56.63M | 70.51M | 63.06M |
| Depreciation & Amortization | 285.26M | 287.51M | 167.63M | 115.84M | 109.29M | 112.68M | 67.5M | 53.1M |
| Stock-Based Compensation | 48.01M | 38.78M | 79M | 69.74M | 77.48M | 67.53M | 10.8M | 8.15M |
| Deferred Taxes | 38.2M | 26.05M | 24.22M | 36.66M | 14.54M | -1.15M | 203K | -800K |
| Other Non-Cash Items | -187.42M | 114.45M | 43.49M | 22.59M | 45.94M | 67.23M | 27.89M | 5.56M |
| Working Capital Changes | 131.66M | -37.28M | -29.38M | 37.9M | -74.99M | -29.44M | -41.51M | 20.44M |
| Cash from Investing | -247.02M | -834.01M | -1.76B | -476.23M | -22.42M | -457.94M | -768.51M | -148M |
| Capital Expenditures | -61.84M | -67.95M | -47M | -29.78M | -15.04M | -9.78M | -12.5M | -7.99M |
| Acquisitions | -181.28M | -746.49M | -1.71B | -446.68M | 0 | -108.88M | -741.46M | -144.4M |
| Purchase of Investments | 0 | -16.56M | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -3.91M | -3.01M | 0 | 228K | -7.38M | -339.27M | -14.55M | 4.39M |
| Cash from Financing | -66M | 78.12M | 1.17B | -12.61M | 314.76M | 429.28M | 1.13B | 62.27M |
| Dividends Paid | -65.57M | -62.34M | -80.24M | -71.67M | -39.88M | -47.1M | -50.12M | -72.29M |
| Share Repurchases | -303.75M | -3.73M | -27.46M | -8.79M | -7.17M | -967.85M | -52.56M | -3.17M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 1.45B | 0 | 0 |
| Debt Issuance (Net) | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K |
| Other Financing | -69.75M | 89.79M | -37.55M | 12.68M | -15.66M | 92.12M | 176.2M | 58.91M |
| Net Change in Cash | 244.12M | -96.33M | -75.53M | -11.05M | 627.72M | 243.96M | 493.54M | 64.05M |
| Exchange Rate Effect | -1.38M | 15.89M | -1.51M | 584K | -126K | -883K | 1.35M | 265K |
| Cash at Beginning | 1.48B | 1.68B | 1.76B | 1.77B | 1.14B | 895.7M | 402.16M | 338.11M |
| Cash at End | 1.76B | 1.58B | 1.68B | 1.76B | 1.77B | 1.14B | 895.7M | 402.16M |
| Free Cash Flow | 496.69M | 575.71M | 467.87M | 447.43M | 320.47M | 263.71M | 122.89M | 141.52M |
| FCF Growth % | -2.69% | 23.05% | 4.57% | 39.62% | 21.52% | 114.58% | -13.16% | - |
| FCF Margin % | 15.44% | 18.87% | 18.6% | 21.54% | 18.58% | 18.41% | 12.07% | 18.5% |
| FCF per Share | - | 2.07 | 1.7 | 3.56 | 1.21 | 2.49 | 1.15 | 1.33 |
Quick answers to the most common questions about buying RYAN stock.
Ryan Specialty Holdings, Inc. (RYAN) generated $643.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Ryan Specialty Holdings, Inc. (RYAN) generated $575.7M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Ryan Specialty Holdings, Inc. (RYAN) spent $68.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Ryan Specialty Holdings, Inc. (RYAN) returned $62.3M to shareholders via cash dividends and spent $3.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Volatile loss ratio and reserve adequacy
Metrics are mathematically derived from official filings.
Underwriting Cash Flow Swings Sharply
Ryan Specialty's operating cash flow swung from -$167.4M in 2026Q1 to $293.0M in 2026Q2, reflecting a $957.4M claims payout in Q2, as per recent SEC filings.
The dramatic quarter-over-quarter swing in operating cash flow underscores the inherent volatility in specialty underwriting. The $957.4M claims payment in 2026Q2, following a modest $69.4M in Q1, suggests a large loss event or adverse development that may strain liquidity. Despite this, the company generated positive OCF in most quarters, indicating that premium collections generally outpace claims payments, but the magnitude of swings warrants close monitoring.
Claims Payments Spike in Q2 2026
Claims paid surged to $957.4M in 2026Q2 from $69.4M in Q1, a 13-fold increase, as reported in the cash flow statement, signaling potential reserve strain.
The spike in claims payments aligns with the prior income statement analysis showing a loss ratio of 104.4% in 2026Q2, indicating underwriting losses. This suggests that the company may have experienced a significant catastrophe or adverse development, and the cash outflow may not be fully covered by operating cash flow in that quarter. Investors should assess whether this is a one-off event or a trend, as it directly impacts float and investment capacity.
Earnings Quality Questioned by Cash Flow Divergence
In 2026Q2, net income of $108.4M was accompanied by OCF of $293.0M, but the $957.4M claims payout suggests non-cash accruals may be masking underwriting losses, per the cash flow statement.
The divergence between net income and operating cash flow, particularly in quarters with high claims, indicates that reported earnings may not fully reflect cash realities. For instance, 2026Q1 showed a net loss of $27.6M but OCF of -$167.4M, implying that accruals for future claims or reserve releases are influencing reported profitability. This warrants scrutiny of reserve adequacy and the sustainability of earnings.
Buybacks and Dividends Outpace Cash Generation
Ryan Specialty returned $277.1M to shareholders in 2026Q2 via buybacks and dividends, exceeding the quarter's OCF of $293.0M, as per the cash flow statement.
The aggressive capital return, particularly the $260.2M buyback in 2026Q2, appears to be funded by operating cash flow and possibly existing cash reserves. While the company generated positive OCF in most quarters, the sustainability of such returns is questionable given the volatility in claims payments. If claims remain elevated, the company may need to reduce distributions or rely on portfolio liquidation, which could impact investment income.
What the Cash Flow Statement Obscures
The cash flow statement shows no investment purchases or sales, yet the company's float likely generates investment income; this omission may obscure the true cash generation, based on reported data.
The absence of investment portfolio activity in the cash flow data is notable for an insurance carrier. It may indicate that investment income is minimal or that the data is incomplete. However, the lack of purchases or sales suggests that the company is not actively managing its portfolio, which could limit yield enhancement. Additionally, the high claims payout in 2026Q2 may signal reinsurance recoverables that are not reflected in the cash flow, posing credit risk if reinsurers fail to pay.